Capstone Investment Advisors, LLC Paratek Pharmaceuticals, Inc. Transaction History

Capstone Investment Advisors, LLC

  • $38.9 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$4.8 - $11.6 $61,920 - $149,640
-12,900 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$9.05 - $10.95 $304,985 - $369,015
-33,700 Reduced 72.32%
12,900 $125,000
Q2 2018

Aug 13, 2018
BUY
$10.2 - $13.9 $475,319 - $647,740
46,600 New
46,600 $475,000

Others Institutions Holding PRTK

# of Institutions
4
Shares Held
1.54M
Call Options Held
0
Put Options Held
0
View Full List

About Paratek Pharmaceuticals, Inc.

PRTK Quotes by TradingView
  • Ticker PRTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,862,500
  • Description
  • Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...
More about PRTK
Track This Portfolio

Track Capstone Investment Advisors, LLC Portfolio

Follow Capstone Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email